PRI Introduces EmPRO
ROSLYN, N.Y. – September 14, 2020 – EmPRO, a new insurer capitalized with over $100 million that is domiciled and authorized to write medical professional liability business in the State of New York, officially launched today.
Owned by Physicians’ Reciprocal Insurers (“PRI”), the third-largest admitted medical professional liability insurer in New York State, EmPRO is administered by PRIMMA LLC , PRI’s wholly owned Attorney-in-Fact. Current PRI insureds will be transitioned to EmPRO when their policies renew without any interruption in coverage, and all new policies will be written through EmPRO.
“The creation of EmPRO is a critical step in continuing our mission to support and defend New York physicians and healthcare facilities, as we have for nearly four decades,” said Bruce Shulan, Vice Chairman, President and CEO of PRI. “EmPRO will expand upon PRI’s legacy—an insurer created by doctors, for doctors—and we’re confident that insureds and the broker community will embrace this new company that combines deep market experience with a strong balance sheet.”
EmPRO will maintain the same exceptional customer service, products, innovative technology, expert claims handling, and strong defense that PRI policyholders have come to expect as its business will be administered by the same team responsible for PRI’s remarkable turnaround.
“The launch of EmPRO is a welcome development for the New York State medical community,” said Bill Carey, Managing Director – Healthcare Practice, Arthur J. Gallagher & Company. “EmPRO’s strong capitalization reflects a real dedication to the physicians, practices and facilities it insures. Now more New York medical professionals and healthcare facilities can access the best-in-class service and strong defense that PRI and PRIMMA are known for.”
EmPRO’s launch follows a meaningful turnaround at PRI over the past three years, which saw a significant improvement to its financial position as well as extensive operational enhancements. As of its most recent financial statement filing, EmPRO had approximately $10.4 million of surplus, with a subsequent capital infusion increasing EmPRO’s surplus to over $100 million.